CD274 and neoplasm: These mechanisms include inducing immunogenic cell death, increasing the expression of major histocompatibility complex class I (MHC-I) molecules, releasing tumor cell neoantigens, modulating immune suppressive cells, and upregulating programmed cell death ligand 1 (PD-L1) expression on tumor cells.